Fentanyl test strips are saving lives, but that's just the beginning.

Published Date: 16 Feb 2023

Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.

Read Full News

Latest News

Meningitis Survivors May Face Slightly Higher Death Risk

Survivors of bacterial meningitis have modestly higher mortality than their peers over nearly six decades, and their siblings do too — suggesting that familial factors may play a role.

Chemours, DuPont, Corteva Settle North Carolina 'forever Chemicals' claims For $455 Million

Chemours, DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina ⁠and 11 local entities over PFAS contamination claims tied to Chemours'...

10 Medical Myths: How Many Do You Still Believe?

From colonoscopy preparation to antibiotic use and wound care, familiar recommendations may not always reflect the current evidence or best clinical practice.

NHS Logs Busiest Summer Yet as A&E Waits Persist

NHS staff in England treated more A&E patients within 4 hours than ever, even as waiting lists and corridor care worsened.

Deep Learning System Detects Lesions in Sacroiliac Joints

A deep learning system matches experts in identifying active and structural lesions in MRI scans of sacroiliac joints in patients with axial spondyloarthritis.

Inherited Risk Measure May Stratify Early-Onset CRC Risk

An integrated inherited risk measure may stratify the risk for early-onset colorectal cancer in adults younger than 50 years, a study finds.

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Todays Updates

First-Line T-DXd Boosts PFS in HER2-Mutant NSCLC

DESTINY-Lung04 supports trastuzumab deruxtecan as a new frontline option for patients with advanced HER2-mutant disease, though it failed to improve overall survival.

Could Burnout Become the Employer’s Responsibility?

A European Parliament committee is backing employer risk assessments to tackle burnout. But should that mean new binding EU rules?

High CLL Remission Seen With First-Line Triplet Regimen

High 2-year survival rates are seen in treatment-naive patients with CLL receiving a noncovalent BTK inhibitor combined with venetoclax and obinutuzumab.

FET-PET Agent Approved for Glioma Imaging

Floretyrosine F18 is the first amino acid PET imaging agent approved for glioma in the United States.

Latest News

Survivors of bacterial meningitis have modestly higher mortality than their peers over nearly six decades, and their siblings do too — suggesting that familial factors may play a role.

Chemours, DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina ⁠and 11 local entities over PFAS contamination claims tied to Chemours'...

From colonoscopy preparation to antibiotic use and wound care, familiar recommendations may not always reflect the current evidence or best clinical practice.

NHS staff in England treated more A&E patients within 4 hours than ever, even as waiting lists and corridor care worsened.

A deep learning system matches experts in identifying active and structural lesions in MRI scans of sacroiliac joints in patients with axial spondyloarthritis.

An integrated inherited risk measure may stratify the risk for early-onset colorectal cancer in adults younger than 50 years, a study finds.

News All Time

Flucloxacillin Tied to Kidney Injury Risk in Bacteremia

Patients with Staphylococcus aureus bacteremia treated with flucloxacillin vs cefazolin are more likely to develop kidney injury, with most cases occurring within the first week of treatment.

Bangladesh Dengue Outbreak Accelerates; Hospitals Under Strain

Bangladesh's dengue outbreak is accelerating, with 42,590 people hospitalised and 117 deaths recorded this year, as a sharp September surge strains hospitals.

Indonesian Rights Body Calls for Probe Into Student Food Poisoning

Indonesia's top human rights body urged police to investigate new outbreaks of food poisoning linked to the president's ⁠programme to provide free student meals.

Cyclosporiasis outbreak Exposes a Weakened US public Health System

During the height of the summer outbreak of cyclosporiasis, Dea Lancaster set aside her usual duties as nurse coordinator at Michigan's Washtenaw County Health Department to...

Pharmacies Call for Tougher Response to Increasing Crime

An NPA survey found most pharmacies faced shoplifting, break-ins, or abuse last year, and almost a third did not report incidents to police.

Substance Use Screening Varies at Provider, Clinic Levels

Variation in alcohol and drug screening is seen at provider and clinic levels; factors such as need for an interpreter and alcohol-related cognitive disorders are tied to lower screening probability.

More Than 1,700 Fall Sick From Indonesia Free School Meals in Three Days

Another 777 students and teachers contracted food poisoning in Indonesia's Central Java after consuming government-issued free meals, a school principal said on Thursday,...

Suspected Food Poisoning From Free School Meals in Indonesia

More than 500 students in Indonesia's East Java were hospitalised with food poisoning suspected to have been caused by free meals provided by the ⁠government.

12% of Patients With ALS Survive at Least 10 Years

A German population-based registry study identifies survival patterns and predictors of longer survival in patients with amyotrophic lateral sclerosis.

Diverted Pouches: Worse Strictures, Same Endoscopic Fix

In patients with diverted ileal pouches, severe strictures and pouchitis frequently coexist, but endoscopic stricturotomy remains feasible and safe despite more severe disease.

Tick-Borne Encephalitis Tied to Long-Term Cognitive Issues

At 12 months, patients with tick-borne encephalitis have significantly more memory lapses and symptom burden than matched control individuals, a study shows.

Ketamine and Psychotherapy: A Winning Combination?

New research adds to the data suggesting a benefit of pairing ketamine with psychotherapy for treating pain and other conditions.

Atypical C difficile Tied to Treatment Delays, Deaths

When Clostridioides difficile infection presents without initial diarrhea, diagnostic delays stretch longer and mortality more than doubles compared with typical presentations.

Model IDs Adolescents With Cancer With High Acute Event Risk

A validated risk model predicts acute care events in adolescent and young adult patients with cancer during the early posttreatment period.

Giardia Cases in England at Highest Level in Almost a Decade

UKHSA data show cases rose 11.4% in 2025, with adults aged 30-39 and Londoners most affected.

Corrosion Alert for Cobalt Chrome Hip Replacements

UK regulator flags wear and corrosion risks in five cobalt-chrome hip implant systems, advising clinical review for affected patients.

Recommended News For You

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC

What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

The way that miR-377 inhibits cells that cause prostate cancer.

Recommended Articles For You

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide 

Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology 

Next-Generation Bone Marrow Harvest Technologies 

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inside the Major Findings From the NHS-Galleri Trial

2.

De-escalation Misses the Mark in Inflammatory Breast Cancer

3.

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

4.

Minimally invasive prostate cancer treatment shows success in first patient

5.

Why are so many young adults getting cancer?

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology

3.

Understanding Mean Corpuscular Volume: A Comprehensive Guide 

4.

Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics

5.

The latest Hematocrit: An Overview of Red Blood Cell Health 

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Latest Advances in Hematology

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

3.

Emerging Concepts in Hematology

4.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot